| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CYBB mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1350492 | 6480464 | Estradiol inhibits the reaction [AGT protein results in increased expression of CYBB mRNA]; more ... | CTD | PMID:16097371 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CYBB protein | CTD | PMID:21670166 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1350492 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [NCF1 protein binds to CYBB protein]; more ... | CTD | PMID:20299304 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | multiple interactions | EXP | | 6480464 | nebivolol inhibits the reaction [AGT protein results in increased expression of CYBB mRNA] | CTD | PMID:16940222 |
| 2-butoxyethanol | decreases expression | ISO | RGD:733265 | 6480464 | n-butoxyethanol results in decreased expression of CYBB mRNA | CTD | PMID:19812364 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:1350492 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [NCF1 protein binds to CYBB protein]; more ... | CTD | PMID:20299304 |
| 4-hydroxynon-2-enal | increases abundance | ISO | RGD:733265 | 6480464 | CYBB protein results in increased abundance of 4-hydroxy-2-nonenal | CTD | PMID:19417757 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | EXP | | 6480464 | AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] | CTD | PMID:21195169 |
| acetaldehyde | increases expression | ISO | RGD:1350492 | 6480464 | Acetaldehyde results in increased expression of CYBB mRNA | CTD | PMID:18845238 |
| acetylcholine | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB gene mutant form inhibits the reaction [Nitroglycerin results in decreased susceptibility to Acetylcholine] | CTD | PMID:18522491 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1350492 | 6480464 | Tretinoin results in increased expression of CYBB mRNA | CTD | PMID:15498508 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1350492 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CYBB mRNA | CTD | PMID:15894607 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1350492 | 6480464 | Tretinoin results in increased expression of CYBB mRNA | CTD | PMID:15498508 PMID:15894607 |
| amlodipine | multiple interactions | EXP | | 6480464 | Amlodipine promotes the reaction [candesartan results in decreased expression of CYBB] | CTD | PMID:21107329 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYBB mRNA | CTD | PMID:16483693 |
| apocynin | multiple interactions | ISO | RGD:1350492 | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] | CTD | PMID:19878672 |
| arsenic atom | decreases expression | ISO | RGD:733265 | 6480464 | Arsenic results in decreased expression of CYBB mRNA | CTD | PMID:19654921 |
| benzo[a]pyrene | decreases expression | ISO | RGD:733265 | 6480464 | Benzo(a)pyrene results in decreased expression of CYBB mRNA | CTD | PMID:21569818 |
| bezafibrate | increases expression | ISO | RGD:733265 | 6480464 | Bezafibrate results in increased expression of CYBB protein | CTD | PMID:20594415 |
| cadmium dichloride | increases expression | ISO | RGD:1350492 | 6480464 | Cadmium Chloride results in increased expression of CYBB protein | CTD | PMID:21195169 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein]; more ... | CTD | PMID:21195169 |
| candesartan | multiple interactions | EXP | | 6480464 | Amlodipine promotes the reaction [candesartan results in decreased expression of CYBB]; more ... | CTD | PMID:21107329 |
| candesartan | decreases expression | EXP | | 6480464 | candesartan results in decreased expression of CYBB mRNA | CTD | PMID:16685210 |
| candesartan | decreases expression | EXP | | 6480464 | candesartan results in decreased expression of CYBB | CTD | PMID:21107329 |
| capsaicin | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein affects the reaction [TRPV1 protein results in increased susceptibility to Capsaicin] | CTD | PMID:18203709 |
| chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of CYBB mRNA | CTD | PMID:23125180 |
| cobalt atom | decreases expression | EXP | | 6480464 | Cobalt results in decreased expression of CYBB mRNA | CTD | PMID:17967803 |
| cocaine | increases expression | ISO | RGD:733265 | 6480464 | Cocaine results in increased expression of CYBB protein | CTD | PMID:18952886 |
| cocaine | increases response to substance | ISO | RGD:733265 | 6480464 | CYBB results in increased susceptibility to Cocaine | CTD | PMID:18952886 |
| D-glucose | multiple interactions | ISO | RGD:733265 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; more ... | CTD | PMID:21925195 |
| D-glucose | multiple interactions | ISO | RGD:1350492 | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] | CTD | PMID:19878672 |
| D-glucose | increases localization | EXP | | 6480464 | Glucose results in increased localization of CYBB protein | CTD | PMID:22253932 |
| dexamethasone | multiple interactions | ISO | RGD:1350492 | 6480464 | Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA] | CTD | PMID:9794432 |
| dextran sulfate | increases expression | ISO | RGD:733265 | 6480464 | Dextran Sulfate results in increased expression of CYBB protein | CTD | PMID:20637373 |
| diarsenic trioxide | decreases expression | ISO | RGD:1350492 | 6480464 | arsenic trioxide results in decreased expression of CYBB mRNA | CTD | PMID:20458559 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1350492 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CYBB mRNA | CTD | PMID:15894607 |
| dichlorvos | increases expression | EXP | | 6480464 | Dichlorvos results in increased expression of CYBB mRNA; more ... | CTD | PMID:21964614 |
| dioxygen | multiple interactions | ISO | RGD:733265 | 6480464 | Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]; more ... | CTD | PMID:21925195 |
| doxorubicin | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein promotes the reaction [[Doxorubicin co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:17275678 |
| eckol | decreases expression | ISO | RGD:1350492 | 6480464 | eckol results in decreased expression of CYBB protein | CTD | PMID:21514314 |
| edaravone | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] | CTD | PMID:18643790 |
| ethanol | increases expression | ISO | RGD:1350492 | 6480464 | Ethanol results in increased expression of CYBB mRNA | CTD | PMID:18845238 |
| folic acid | increases response to substance | ISO | RGD:733265 | 6480464 | CYBB results in increased susceptibility to Folic Acid | CTD | PMID:21647593 |
| folic acid | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein affects the reaction [Folic Acid deficiency results in increased chemical synthesis of Superoxides]; more ... | CTD | PMID:20116427 |
| folic acid | affects response to substance | ISO | RGD:733265 | 6480464 | CYBB protein affects the susceptibility to Folic Acid deficiency | CTD | PMID:20116427 |
| folic acid | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB mutant form inhibits the reaction [Folic Acid deficiency results in decreased expression of CDH3 protein]; more ... | CTD | PMID:21647593 |
| fructose | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with Fructose] results in increased expression of CYBB mRNA | CTD | PMID:19632207 |
| glucose | multiple interactions | ISO | RGD:733265 | 6480464 | [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; more ... | CTD | PMID:21925195 |
| glucose | multiple interactions | ISO | RGD:1350492 | 6480464 | acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein] | CTD | PMID:19878672 |
| glucose | increases localization | EXP | | 6480464 | Glucose results in increased localization of CYBB protein | CTD | PMID:22253932 |
| hydrogen peroxide | increases expression | ISO | RGD:1350492 | 6480464 | Hydrogen Peroxide results in increased expression of CYBB protein | CTD | PMID:19401454 |
| ketamine | increases expression | ISO | RGD:733265 | 6480464 | Ketamine results in increased expression of CYBB | CTD | PMID:18063801 |
| L-methionine | multiple interactions | ISO | RGD:733265 | 6480464 | Methionine inhibits the reaction [Acetaminophen results in increased expression of CYBB mRNA] | CTD | PMID:19739265 |
| lead diacetate | affects expression | ISO | RGD:733265 | 6480464 | lead acetate affects the expression of CYBB mRNA | CTD | PMID:21829687 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of CYBB mRNA | CTD | PMID:22641619 |
| lead diacetate | increases expression | ISO | RGD:1350492 | 6480464 | lead acetate results in increased expression of CYBB protein | CTD | PMID:15569323 |
| malonaldehyde | increases abundance | ISO | RGD:733265 | 6480464 | CYBB protein results in increased abundance of Malondialdehyde | CTD | PMID:19417757 |
| medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | [Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CYBB protein | CTD | PMID:21670166 |
| microcystin-LR | increases expression | ISO | RGD:733265 | 6480464 | cyanoginosin LR results in increased expression of CYBB mRNA | CTD | PMID:17654400 |
| morphine | increases expression | ISO | RGD:733265 | 6480464 | Morphine results in increased expression of CYBB protein | CTD | PMID:14871405 |
| morphine | multiple interactions | ISO | RGD:733265 | 6480464 | Saquinavir inhibits the reaction [Morphine results in increased expression of CYBB protein] | CTD | PMID:14871405 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] | CTD | PMID:21195169 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA | CTD | PMID:18643790 |
| N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | phenylmethylpyrazolone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CYBB mRNA] | CTD | PMID:18643790 |
| NADP zwitterion | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein promotes the reaction [[Doxorubicin co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:17275678 |
| NADP(+) | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein promotes the reaction [[Doxorubicin co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:17275678 |
| nitroglycerin | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB gene mutant form inhibits the reaction [Nitroglycerin results in decreased susceptibility to Acetylcholine] | CTD | PMID:18522491 |
| nitroglycerin | decreases expression | EXP | | 6480464 | Nitroglycerin results in decreased expression of CYBB mRNA | CTD | PMID:17493633 |
| nitroglycerin | increases expression | ISO | RGD:733265 | 6480464 | Nitroglycerin results in increased expression of CYBB mRNA | CTD | PMID:16633368 |
| nitroglycerin | multiple interactions | ISO | RGD:733265 | 6480464 | rosuvastatin inhibits the reaction [Nitroglycerin results in increased expression of CYBB mRNA] | CTD | PMID:16633368 |
| nitroglycerin | decreases response to substance | ISO | RGD:733265 | 6480464 | CYBB gene mutant form results in decreased susceptibility to Nitroglycerin | CTD | PMID:18522491 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of CYBB mRNA | CTD | PMID:23358140 |
| paracetamol | multiple interactions | ISO | RGD:733265 | 6480464 | Methionine inhibits the reaction [Acetaminophen results in increased expression of CYBB mRNA]; more ... | CTD | PMID:19739265 |
| paracetamol | increases expression | ISO | RGD:733265 | 6480464 | Acetaminophen results in increased expression of CYBB mRNA | CTD | PMID:19739265 |
| phenobarbital | affects expression | ISO | RGD:733265 | 6480464 | Phenobarbital affects the expression of CYBB mRNA | CTD | PMID:23091169 |
| phenol | increases expression | EXP | | 6480464 | Phenol results in increased expression of CYBB mRNA | CTD | PMID:16785328 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1350492 | 6480464 | Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA] | CTD | PMID:9794432 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1350492 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA | CTD | PMID:9794432 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin analog inhibits the reaction [AGT protein results in increased expression of CYBB mRNA] | CTD | PMID:19794523 |
| ramipril | decreases expression | ISO | RGD:733265 | 6480464 | Ramipril results in decreased expression of CYBB mRNA | CTD | PMID:16891913 |
| resveratrol | decreases expression | ISO | RGD:733265 | 6480464 | resveratrol results in decreased expression of CYBB protein | CTD | PMID:19478208 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CYBB mRNA | CTD | PMID:20081535 |
| rosuvastatin | decreases expression | EXP | | 6480464 | rosuvastatin results in decreased expression of CYBB | CTD | PMID:21562509 |
| rosuvastatin | multiple interactions | EXP | | 6480464 | [[[rosuvastatin results in decreased expression of CYBB] co-treated with [rosuvastatin results in decreased expression of CYBA]] co-treated with [rosuvastatin results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species | CTD | PMID:21562509 |
| rosuvastatin | multiple interactions | ISO | RGD:733265 | 6480464 | rosuvastatin inhibits the reaction [Nitroglycerin results in increased expression of CYBB mRNA] | CTD | PMID:16633368 |
| saquinavir | multiple interactions | ISO | RGD:733265 | 6480464 | Saquinavir inhibits the reaction [Morphine results in increased expression of CYBB protein] | CTD | PMID:14871405 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] | CTD | PMID:21195169 |
| spironolactone | decreases expression | EXP | | 6480464 | Spironolactone results in decreased expression of CYBB protein | CTD | PMID:19114643 |
| streptozocin | increases expression | ISO | RGD:733265 | 6480464 | Streptozocin results in increased expression of CYBB protein | CTD | PMID:21381899 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CYBB protein | CTD | PMID:19957251 |
| streptozocin | multiple interactions | ISO | RGD:733265 | 6480464 | telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] | CTD | PMID:21381899 |
| superoxide | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein promotes the reaction [[Doxorubicin co-treated with NADP] results in increased abundance of Superoxides] | CTD | PMID:17275678 |
| superoxide | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB protein affects the reaction [Folic Acid deficiency results in increased chemical synthesis of Superoxides]; more ... | CTD | PMID:20116427 |
| superoxide | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB mutant form inhibits the reaction [Homocysteine results in increased abundance of Superoxides] | CTD | PMID:21647593 |
| superoxide | multiple interactions | ISO | RGD:1350492 | 6480464 | IL1B protein promotes the reaction [CYBB protein results in increased chemical synthesis of Superoxides] | CTD | PMID:16354686 |
| tamibarotene | increases expression | ISO | RGD:1350492 | 6480464 | Am 80 results in increased expression of CYBB mRNA; more ... | CTD | PMID:15498508 |
| telmisartan | multiple interactions | ISO | RGD:733265 | 6480464 | telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] | CTD | PMID:21381899 |
| telmisartan | decreases expression | EXP | | 6480464 | telmisartan results in decreased expression of CYBB mRNA | CTD | PMID:19171132 |
| tetrachloromethane | multiple interactions | ISO | RGD:733265 | 6480464 | CYBB gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A2 mRNA]; more ... | CTD | PMID:17105591 |
| tetrachloromethane | decreases response to substance | ISO | RGD:733265 | 6480464 | CYBB gene mutant form results in decreased susceptibility to Carbon Tetrachloride | CTD | PMID:17105591 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYBB protein | CTD | PMID:17854599 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CYBB mRNA | CTD | PMID:17854599 |
| thioacetamide | multiple interactions | EXP | | 6480464 | salvianolic acid A inhibits the reaction [Thioacetamide results in increased expression of CYBB protein]; more ... | CTD | PMID:19822164 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CYBB protein | CTD | PMID:19822164 |
| trans-resveratrol | decreases expression | ISO | RGD:733265 | 6480464 | resveratrol results in decreased expression of CYBB protein | CTD | PMID:19478208 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CYBB mRNA | CTD | PMID:20081535 |
| valsartan | multiple interactions | ISO | RGD:1350492 | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of CYBB mRNA]; more ... | CTD | PMID:15643130 |
| vanadyl sulfate | decreases expression | ISO | RGD:1350492 | 6480464 | vanadyl sulfate results in decreased expression of CYBB mRNA | CTD | PMID:16330358 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of CYBB | CTD | PMID:20128680 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of CYBB | CTD | PMID:20128680 |